NeuroPace, Inc.
NPCE
$15.96
$0.332.11%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -21.57M | -21.47M | -23.99M | -25.94M | -24.81M |
| Total Depreciation and Amortization | 2.00M | 1.95M | 1.88M | 1.84M | 1.81M |
| Total Amortization of Deferred Charges | 256.00K | 237.00K | 223.00K | 200.00K | 199.00K |
| Total Other Non-Cash Items | 11.92M | 12.29M | 12.53M | 12.54M | 12.07M |
| Change in Net Operating Assets | -2.03M | -4.01M | -6.95M | -4.73M | -7.18M |
| Cash from Operations | -9.42M | -11.01M | -16.31M | -16.09M | -17.90M |
| Capital Expenditure | -412.00K | -332.00K | -274.00K | -344.00K | -239.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 2.00M | 3.50M | 6.80M |
| Cash from Investing | -412.00K | -332.00K | 1.73M | 3.16M | 6.56M |
| Total Debt Issued | 58.44M | 58.44M | 58.44M | 58.57M | -- |
| Total Debt Repaid | -60.51M | -60.51M | -60.51M | -60.51M | -- |
| Issuance of Common Stock | 938.00K | 71.81M | 72.03M | 74.99M | 75.37M |
| Repurchase of Common Stock | -540.00K | -50.14M | -50.14M | -50.11M | -50.01M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.67M | 19.60M | 19.81M | 22.95M | 25.36M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.51M | 8.26M | 5.23M | 10.01M | 14.02M |